Literature DB >> 21366602

The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans.

Graham Simmons1, Simone A Glynn, Jerry A Holmberg, John M Coffin, Indira K Hewlett, Shyh-Ching Lo, Judy A Mikovits, William M Switzer, Jeffrey M Linnen, Michael P Busch.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21366602      PMCID: PMC3071162          DOI: 10.1111/j.1537-2995.2011.03063.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  39 in total

1.  Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases.

Authors:  K M Bell; D Cookfair; D S Bell; P Reese; L Cooper
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

2.  Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome.

Authors:  Harriet C T Groom; Virginie C Boucherit; Kerry Makinson; Edward Randal; Sarah Baptista; Suzanne Hagan; John W Gow; Frank M Mattes; Judith Breuer; Jonathan R Kerr; Jonathan P Stoye; Kate N Bishop
Journal:  Retrovirology       Date:  2010-02-15       Impact factor: 4.602

3.  Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States.

Authors:  William M Switzer; Hongwei Jia; Oliver Hohn; HaoQiang Zheng; Shaohua Tang; Anupama Shankar; Norbert Bannert; Graham Simmons; R Michael Hendry; Virginia R Falkenberg; William C Reeves; Walid Heneine
Journal:  Retrovirology       Date:  2010-07-01       Impact factor: 4.602

4.  Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.

Authors:  B Wang; M J Higgins; S Kleinman; G B Schreiber; E L Murphy; S A Glynn; D J Wright; C C Nass; D Chang; M P Busch
Journal:  Transfusion       Date:  2004-08       Impact factor: 3.157

5.  Virology. A new virus for old diseases?

Authors:  John M Coffin; Jonathan P Stoye
Journal:  Science       Date:  2009-10-08       Impact factor: 47.728

6.  Disease-associated XMRV sequences are consistent with laboratory contamination.

Authors:  Stéphane Hué; Eleanor R Gray; Astrid Gall; Aris Katzourakis; Choon Ping Tan; Charlotte J Houldcroft; Stuart McLaren; Deenan Pillay; Andrew Futreal; Jeremy A Garson; Oliver G Pybus; Paul Kellam; Greg J Towers
Journal:  Retrovirology       Date:  2010-12-20       Impact factor: 4.602

7.  Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections.

Authors:  Eleanor Barnes; Peter Flanagan; Anthony Brown; Nicola Robinson; Helen Brown; Myra McClure; Annette Oxenius; Jane Collier; Jonathan Weber; Huldrych F Günthard; Bernard Hirschel; Sarah Fidler; Rodney Phillips; John Frater
Journal:  J Infect Dis       Date:  2010-10-11       Impact factor: 5.226

8.  Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome.

Authors:  Ping Hong; Jinming Li; Yongzhe Li
Journal:  Virol J       Date:  2010-09-13       Impact factor: 4.099

9.  Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies.

Authors:  Xiaoxing Qiu; Priscilla Swanson; Ka-Cheung Luk; Bailin Tu; Francois Villinger; Jaydip Das Gupta; Robert H Silverman; Eric A Klein; Sushil Devare; Gerald Schochetman; John Hackett
Journal:  Retrovirology       Date:  2010-08-17       Impact factor: 4.602

10.  Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients.

Authors:  Oliver Hohn; Hans Krause; Pia Barbarotto; Lars Niederstadt; Nadine Beimforde; Joachim Denner; Kurt Miller; Reinhard Kurth; Norbert Bannert
Journal:  Retrovirology       Date:  2009-10-16       Impact factor: 4.602

View more
  17 in total

Review 1.  Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply.

Authors:  Andrew D Johnson; Claudia S Cohn
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

2.  Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study.

Authors:  Graham Simmons; Simone A Glynn; Anthony L Komaroff; Judy A Mikovits; Leslie H Tobler; John Hackett; Ning Tang; William M Switzer; Walid Heneine; Indira K Hewlett; Jiangqin Zhao; Shyh-Ching Lo; Harvey J Alter; Jeffrey M Linnen; Kui Gao; John M Coffin; Mary F Kearney; Francis W Ruscetti; Max A Pfost; James Bethel; Steven Kleinman; Jerry A Holmberg; Michael P Busch
Journal:  Science       Date:  2011-09-22       Impact factor: 47.728

3.  Development of sensitive single-round pol or env RT-PCR assays to screen for XMRV in multiple sample types.

Authors:  Ning Tang; Andrea Frank; Gregor Leckie; John Hackett; Graham Simmons; Michael Busch; Klara Abravaya
Journal:  J Virol Methods       Date:  2011-10-25       Impact factor: 2.014

4.  No evidence of xenotropic murine leukemia virus-related virus transmission by blood transfusion from infected rhesus macaques.

Authors:  Dhanya K Williams; Teresa A Galvin; Yamei Gao; Christina O'Neill; Dustin Glasner; Arifa S Khan
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

5.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Authors:  Steven Kleinman; Melissa R King; Michael P Busch; Edward L Murphy; Simone A Glynn
Journal:  Transfus Med Rev       Date:  2012-05-24

6.  In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.

Authors:  Deanna Lee; Jaydip Das Gupta; Christina Gaughan; Imke Steffen; Ning Tang; Ka-Cheung Luk; Xiaoxing Qiu; Anatoly Urisman; Nicole Fischer; Ross Molinaro; Miranda Broz; Gerald Schochetman; Eric A Klein; Don Ganem; Joseph L Derisi; Graham Simmons; John Hackett; Robert H Silverman; Charles Y Chiu
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Identification of XMRV infection-associated microRNAs in four cell types in culture.

Authors:  Ketha V K Mohan; Krishnakumar Devadas; Shilpakala Sainath Rao; Indira Hewlett; Chintamani Atreya
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

8.  Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.

Authors:  Simone A Glynn; Michael P Busch; Roger Y Dodd; Louis M Katz; Susan L Stramer; Harvey G Klein; Graham Simmons; Steven H Kleinman; Susan B Shurin
Journal:  Transfusion       Date:  2012-06-13       Impact factor: 3.157

9.  Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Authors:  M F Kearney; K Lee; R K Bagni; A Wiegand; J Spindler; F Maldarelli; P A Pinto; W M Linehan; C D Vocke; K A Delviks-Frankenberry; R W Devere White; G Q Del Prete; J W Mellors; J D Lifson; V N Kewalramani; V K Pathak; J M Coffin; S F J Le Grice
Journal:  Adv Virol       Date:  2011-11-17

10.  No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.

Authors:  Simin D Rezaei; Anna C Hearps; John Mills; John Pedersen; Gilda Tachedjian
Journal:  Virol J       Date:  2013-01-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.